Our results show that in both the genotypic and the recessive models, patients carrying the VDR BsmI rs1544410-AA genotype had a lower risk of developing NSCLC; the data were adjusted to take account of smoking status and family history of cancer (Table 4). This evidence concerns the gene VDR and cancer.